Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lorber

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Pathology|February 28, 2018
Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event and FKBP4 as a potential driver of castration resistanceJoël R Federer-Gsponer, Cristina Quintavalle, David C Müller, et al.
Journal of Visualized Experiments : Jove|May 4, 2026
Detecting Inter-Individual Contamination and Mismatches in Multiomics Next-Generation Sequencing DataZachary Whitfield, Przemyslaw Kiljan, Monika Krzyzanowska, et al.
Cancer Research|May 18, 2022
Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain MetastasisEster Bonfill-Teixidor, Raffaella Iurlaro, Cornelia Handl, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Pathology|February 28, 2018
Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event and FKBP4 as a potential driver of castration resistanceJoël R Federer-Gsponer, Cristina Quintavalle, David C Müller, et al.
Journal of Visualized Experiments : Jove|May 4, 2026
Detecting Inter-Individual Contamination and Mismatches in Multiomics Next-Generation Sequencing DataZachary Whitfield, Przemyslaw Kiljan, Monika Krzyzanowska, et al.
Cancer Research|May 18, 2022
Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain MetastasisEster Bonfill-Teixidor, Raffaella Iurlaro, Cornelia Handl, et al.
Pageof 2